Dr. Ravi Jain is the Founder of Crams Technologies, a research-driven Contract Research and Manufacturing Services (CRAMS) organization headquartered in Faridabad, Haryana, India, near New Delhi. Under his leadership, Crams Technologies is building a strong foundation as a specialized CRO focused on impurity standards, chemistry services, analytical services, consulting, and outsourcing support for the global pharmaceutical and life sciences industries.
Dr. Ravi holds a Ph.D. in Analytical Chemistry and is a highly accomplished analytical scientist with over four decades of experience in pharmaceutical research and development. He has authored 12 peer-reviewed research publications in journals of international repute, reflecting his deep technical expertise and long-standing contributions to analytical science.
Throughout his career, Dr. Ravi has been closely associated with several leading pharmaceutical research organizations in India. His expertise and leadership were further recognized through his appointment as a Member of the Expert Committee on Analytical Chemistry for the United States Pharmacopeia (USP) from 2000 to 2005, where he contributed to the development and evaluation of global analytical standards.
Dr. Ravi’s scientific excellence has been acknowledged through multiple prestigious awards. He was honored by Ranbaxy Laboratories as Best Scientist for his contributions to Ciprofloxacin research, and by Dabur Research Foundation for his work on Paclitaxel research.
Dr. Ravi’s vision, scientific rigor, and industry insight form the cornerstone of Crams Technologies’ commitment to quality, integrity, and innovation.
